US pharma major Merck (MSD) dropped India from its list of priority markets. Other top multinational pharma companies have also sounded warning bells about India's IPR regime.
first published: Oct 8, 2013 10:32 pm
A collection of the most-viewed Moneycontrol videos.
You are already a Moneycontrol Pro user.

